Formoterol Via pMDI HFA-134a Propellant or DPI in Partially Reversible Chronic Obstructive Pulmonary Disease (COPD)
Clinical trial NCT00742248 · COMPLETED
Trial details
- NCT number
- NCT00742248
- Sponsor
- Chiesi Farmaceutici S.p.A.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2004-09-01
- Primary completion
- 2005-05-01
- Enrollment
- 54
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.